Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Fibrocell Science provides FDA final data from azficel-T histology study

March 18, 2011

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

March 16, 2011

Janssen Pharma launches Stelara in Japan for psoriasis

March 14, 2011

AstraZeneca and Galderma to develop dermatological therapies

March 9, 2011

Clinuvel receives FDA clearance for pilot phase II trial of Scenesse in vitiligo

March 3, 2011

Mochida Pharma requests Japanese approval for Beselna in solar keratoses

March 2, 2011

Sunnybrook Health Sciences and sanofi-aventis to develop vasculotide

Feb. 25, 2011

CalciMedica begins phase I trial of CM-2489 for psoriasis

Feb. 23, 2011

Corticotropin-releasing factor receptor antagonist astressin B activates hair growth in vivo

Feb. 22, 2011

Astellas' Protopic approved in Canada for prevention of eczema flares

Feb. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...